Skip to content
中文产业新闻评分63Chinese source

Jazz Pharmaceuticals以最高13.2亿美元收购罕见病Biotech Actio Biosciences

最高13.2亿美元卖给Jazz！又一罕见病Biotech被收购

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.